This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Jonathan M. Rieber, MD; Robert L. Goodman, MD
Columbia-Presbyterian Medical Center New York, NY

JAMA. 1995;274(1):25-26.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—The article by Dr Hooton and colleagues¹ attempts to standardize therapy for acute cystitis by defining the most efficacious and cost-efficient drug regimen. We agree that the wide variation in clinical practice today clearly indicates the need for this study. However, we disagree with their conclusions.

Hooton et al conclude, "A 3-day regimen of trimethoprim-sulfamethoxazole is more effective and less expensive than 3-day regimens of nitrofurantoin, cefadroxil, or amoxicillin....." In their comparative analysis, only nitrofurantoin was statistically inferior to trimethoprim-sulfamethoxazole (P=.04). Cure rates with amoxicillin and with cefadroxil were not statistically different from cure rates with trimethoprim-sulfamethoxazole (P=.11 for both comparisons).

The study also failed to account for patients who received care at another clinic and patients who received nonstudy antibiotics. Four patients in the cefadroxil group received nonstudy antibiotics and were excluded. Patients in two of the other groups treated at other clinics . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?